Table 4:

Factors Relating to RFS and CRFS in the ‘high risk’ subgroup

	univariate		multivariate
RFS
	HR (95% CI)	p-value	HR (95% CI)	p-value
cytogenetic risk at diagnosis		0.009		0.030
Poor	reference		reference
very poor	2.18 (1.21, 3.92)		1.95 (1.07, 3.58)
blasts at transplant		0.877
< 5 %	reference
5–9 %	1.05 (0.59,1.85)
donor type		0.250
Match	reference
Mismatch	0.50 (0.16,1.62)
conditioning intensity		0.102
Myeloablative	reference
RIC	1.72 (0.90, 3.30)
transplant type		0.049		0.176
CD34 SELECTED	reference		reference
Unmodified	1.84 (1.00, 3.37)		1.54 (0.82, 2.88)
CRFS
	HR (95% CI)	p-value	HR (95% CI)	p-value
cytogenetic risk at diagnosis		0.007		0.048
Poor	reference		reference
very poor	2.21 (1.24, 3.93)		1.82 (1.01, 3.29)
blasts at transplant		0.455
< 5 %	reference
5–9 %	1.24 (0.71, 2.15)
donor type		0.138
Match	reference
Mismatch	0.41 (0.13, 1.33)
conditioning intensity		0.147
Myeloablative	reference
RIC	1.61 (0.85, 3.08)
transplant type		0.002		0.010
CD34 SELECTED	reference		reference
Unmodified	2.68 (1.43, 5.01)		2.31 (1.22, 4.40)
Graft source		0.363
BM	reference
PBSC	0.76 (0.42, 1.38)